Skip to the answer

Cobimetinib Uses, Dosage, Side Effects and Interactions

Brand name
Cotellic

Cotellic was the first cobimetinib product the FDA approved, in November 2015. No generic is listed as tablets.

First generic of Cotellic: our estimate, May 2030

Cobimetinib is a targeted cancer medicine (a kinase inhibitor) used for melanoma with a BRAF V600E or V600K mutation, together with vemurafenib, and on its own for histiocytic neoplasms in adults.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About CobimetinibType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Cobimetinib in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Cobimetinib (Cotellic) is a specialist targeted cancer tablet, on the market since about 2015 with no generic, that blocks MEK1 and MEK2, proteins that relay growth signals; it is paired with vemurafenib for BRAF V600E or V600K melanoma that cannot be removed or has spread, and used alone for histiocytic neoplasms (rare blood cell tumors). Side effects are common, mainly diarrhea, nausea, an acne-like rash and easy sunburn, and your team may pause or lower the dose. Call your team right away for vision changes, breathlessness or swelling, or unusual bleeding such as black stools. Expect regular heart, eye, skin, liver and muscle checks.

Key Takeaways From the HelloPharmacist Team

  • Take it once a day, with or without food, for the first 21 days of each 28-day cycle, then take a week off.
  • If you miss a dose or vomit after taking it, skip that dose and take the next one at the usual time.
  • Protect your skin every day with covering clothes and broad-spectrum SPF 30 or higher sunscreen and lip balm, because sunburn comes on easily.
  • Check with your pharmacist before any new medicine or supplement, since St. John's Wort, rifampin, itraconazole and some antibiotics can change its levels.

How we write and review this content: our editorial policy

Cobimetinib by the Numbers

Strengths
1
in one form
Makers and packagers
1
Earliest FDA record
2015
Rank by Medicaid prescriptions
#1,538 of 1,682 drugs
More prescriptions than 8% of the 1,682 drugs we measure
168 prescriptions, Q1–Q4 2025

Patient Information Guide for Cobimetinib

What It’s Used For

Cobimetinib is a kinase inhibitor used for these cancers in adults:

  • Cotellic, together with vemurafenib, for unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.
  • Cotellic, as a single agent, for histiocytic neoplasms.

How It Works

Cobimetinib reversibly blocks MEK1 and MEK2. These are proteins in a signaling pathway that tells cells to multiply. BRAF V600E and V600K mutations keep that pathway constantly active.

Vemurafenib blocks a different protein in the same pathway. In lab and animal studies, using both drugs together caused more cancer cell death and slowed tumor growth more than either drug alone.

Drug Class

Drug Class

  • Kinase Inhibitor
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Kinase Inhibitor

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)
  • Kinase Inhibitors

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Cobimetinib in the FDA’s index.

From our Patient Information GuideCobimetinib reversibly blocks MEK1 and MEK2. These are proteins in a signaling pathway that tells cells to multiply. BRAF V600E and V600K mutations keep that pathway constantly active. Read How Cobimetinib Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)

None listed for Cobimetinib in the FDA’s index.

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Mitogen-activated protein kinase (MEK) inhibitors

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Cotellic is a tablet taken by mouth once a day for the first 21 days of each 28-day cycle. Treatment continues until the cancer progresses or side effects become unacceptable.

  • Take it with or without food.
  • If you miss a dose or vomit after taking it, skip it and take the next scheduled dose.
  • Your doctor may lower your dose or pause treatment if side effects occur.

Follow your prescriber's instructions and the label.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

Melanoma (skin cancer) that cannot be removed or has spread

For adults · Recommended dose
Usual dose 60 mg once a day
  • 60 mg (three 20 mg tablets) orally taken once daily for the first 21 days of each 28-day cycle until disease progression or unacceptable toxicity

Good to know

Take with or without food

Histiocytic neoplasms (rare blood cell tumors)

For adults · Recommended dose
Usual dose 60 mg once a day
  • 60 mg (three 20 mg tablets) orally taken once daily for the first 21 days of each 28-day cycle until disease progression or unacceptable toxicity

Good to know

Take with or without food

Short-term (14 days or less) concurrent use of moderate CYP3A inhibitors, unavoidable, in patients taking cotellic 60 mg

For adults who must briefly take a moderate CYP3A inhibitor
Usual dose 20 mg

Step by step

  1. Reduce Cotellic dose to 20 mg
  2. After discontinuation of the moderate CYP3A inhibitor, resume Cotellic 60 mg

Good to know

Patients already on a reduced dose (40 or 20 mg daily) should use an alternative to a strong or moderate CYP3A inhibitor

Special Situations

If side effects need a lower dose

Your doctor decides whether to lower your dose for side effects. Never change your dose on your own.

  • First dose reduction

    40 mg orally once daily

  • Second dose reduction

    20 mg orally once daily

Dose reduction, subsequent modification

Permanently discontinue Cotellic if unable to tolerate 20 mg orally once daily

See the Full Dosing Instructions on DailyMed →

Side Effects

The most common side effects reported in people with melanoma (taking it with vemurafenib) include:

Common side effects

  • Diarrhea
  • Nausea
  • Vomiting
  • Sun sensitivity (easy sunburn or rash in sunlight)
  • Fever
  • Acne-like skin rash
  • Tiredness
  • Swelling (edema)

When to get medical help

  • Call your doctor right away for any unusual or serious bleeding, such as black stools, blood in urine, vomiting blood or a severe headache.
  • Get help for new or worsening vision changes. This can signal fluid under the retina or a blocked retinal vein.
  • Report shortness of breath, swelling or tiredness that could signal heart muscle weakness (cardiomyopathy).
  • Call your doctor about a severe rash or other severe skin reaction.
  • Report muscle pain, tenderness or weakness, which can signal rhabdomyolysis (muscle breakdown).
  • Tell your doctor about any new skin growths or suspicious skin changes, including up to 6 months after your last dose.
  • Report signs of liver problems, which your doctor will also check with blood tests.
  • Tell your doctor right away if you become pregnant.

In histiocytic neoplasms, common side effects also include acne-like rash, tiredness, swelling, dry skin, itching, infections and shortness of breath. Contact your doctor promptly about bleeding, vision changes, severe rash, muscle pain or heart-related symptoms.

Warnings and Precautions

  • New cancers: skin and other cancers can occur. Skin checks are done before treatment, every 2 months during treatment and for 6 months after.
  • Bleeding: serious bleeding can occur, including in the brain or stomach and intestines.
  • Heart muscle weakness: heart function is checked before treatment, after one month, then every 3 months.
  • Severe rash and sun sensitivity: avoid sun and use protection.
  • Eye problems: regular eye exams are needed. The drug is stopped permanently for retinal vein occlusion.
  • Liver and muscle: blood tests are done monthly for the liver and periodically for CPK and creatinine.
  • Pregnancy: can cause fetal harm.

Interactions

Cobimetinib is broken down by the liver enzyme CYP3A, so some drugs change its levels.

  • Strong or moderate CYP3A inhibitors (such as itraconazole, erythromycin, ciprofloxacin) can raise levels. Avoid them if possible.
  • Strong or moderate CYP3A inducers (such as carbamazepine, efavirenz, phenytoin, rifampin, St. John's Wort) can sharply lower levels and reduce effectiveness. Avoid them.

Interactions Listed in the FDA-Approved Label

From the Cobimetinib prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.

  • Strong or moderate CYP3A inhibitors For example: itraconazole, erythromycin, ciprofloxacin
    What happensItraconazole (a strong CYP3A4 inhibitor) increased cobimetinib systemic exposure by 6.7-fold.
    What to doAvoid concurrent use. If short-term (14 days or less) use of a moderate inhibitor is unavoidable in patients taking 60 mg, reduce COTELLIC to 20 mg, then resume the previous dose after stopping it. Use an alternative in patients on a reduced dose (40 or 20 mg daily).
  • Strong or moderate CYP3A inducers For example: carbamazepine, efavirenz, phenytoin, rifampin, St. John's Wort
    What happensA strong CYP3A inducer may decrease cobimetinib systemic exposure by more than 80% and reduce its efficacy.
    What to doAvoid concurrent use of COTELLIC and strong or moderate CYP3A inducers.
Read the label’s full interactions text

7 DRUG INTERACTIONS Avoid concomitant administration of COTELLIC with strong or moderate CYP3A inducers or inhibitors. 7.1 Effect of Strong or Moderate CYP3A Inhibitors on COTELLIC Coadministration of COTELLIC with itraconazole (a strong CYP3A4 inhibitor) increased cobimetinib systemic exposure by 6.7-fold. Avoid concurrent use of COTELLIC and strong or moderate CYP3A inhibitors. If concurrent short term (14 days or less) use of moderate CYP3A inhibitors including certain antibiotics (e.g., erythromycin, ciprofloxacin) is unavoidable for patients who are taking COTELLIC 60 mg, reduce COTELLIC dose to 20 mg. After discontinuation of a moderate CYP3A inhibitor, resume COTELLIC at the previous dose. Use an alternative to a strong or moderate CYP3A inhibitor in patients who are taking a reduced dose of COTELLIC (40 or 20 mg daily). 7.2 Effect of Strong or Moderate CYP3A Inducers on COTELLIC Coadministration of COTELLIC with a strong CYP3A inducer may decrease cobimetinib systemic exposure by more than 80% and reduce its efficacy. Avoid concurrent use of COTELLIC and strong or moderate CYP3A inducers including but not limited to carbamazepine, efavirenz, phenytoin, rifampin, and St. John's Wort.

Read the full Drug Interactions section on DailyMed →

Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.

Before You Start

  • Tell your doctor about heart, eye or liver problems.
  • Melanoma needs a confirmed BRAF V600E or V600K mutation.
  • Avoid pregnancy. Use effective contraception during treatment and for 2 weeks after.
  • Do not breastfeed during treatment and for 2 weeks after.
  • It may reduce fertility in women and men.
  • Not established for children.
  • Not enough data in people 65 and older to know if they respond differently.
  • No dose adjustment for mild to moderate kidney problems or any level of liver problems. A dose has not been set for severe kidney problems.

Half-Life and How Your Body Processes It

Cobimetinib is absorbed after you swallow it. Peak blood levels occur after about 2.4 hours, and a high-fat meal does not change absorption. Levels build up and reach steady state in about 9 days.

It is broken down mainly by the liver enzymes CYP3A and UGT2B7. Its half-life is about 44 hours. Most of it leaves in the stool, and very little leaves through the kidneys.

Storage

Store at room temperature below 30°C (86°F).

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Supplements and Herbs That Interact With Cobimetinib

From the licensed clinical database we use, rolled up per supplement, most serious first.

143 supplements and herbal products have documented interactions with Cobimetinib in the licensed clinical database we use.

Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.

  • 3Major
  • 97Moderate
  • 43Minor

See the other 135

Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

Cobimetinib: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Cobimetinib — the kind of thing our pharmacy team would talk through with you at the counter.

What is Cotellic for?

Cotellic (cobimetinib) treats adults with melanoma that can't be removed by surgery or has spread, if the tumor has a BRAF V600E or V600K mutation. For melanoma, you take it with vemurafenib. It is also used by itself for adults with histiocytic neoplasms.

How do I take it?

You take the tablets by mouth once a day for the first 21 days of each 28-day cycle. You can take them with or without food. If you miss a dose or vomit after taking it, just take your next dose at the usual time.

What side effects should I expect?

Diarrhea, nausea, vomiting, fever and sun sensitivity are common. Some people also get skin rashes. Let your care team know if these are hard to manage, because they can adjust your treatment.

When should I call my doctor right away?

Call for unusual bleeding, new vision changes, severe rash, muscle pain or weakness, or shortness of breath and swelling. Also report any new skin growths. These can be signs of serious problems.

How should I protect my skin?

This medicine can make you very sensitive to the sun. Avoid sun exposure and wear protective clothing. Use a broad-spectrum sunscreen and lip balm with SPF 30 or higher when outdoors.

Can I take it if I might get pregnant?

Cobimetinib can harm an unborn baby. Use effective birth control during treatment and for 2 weeks after your last dose. Do not breastfeed during that time either. Tell your doctor right away if you become pregnant.

Is cobimetinib available over the counter?

No. Cobimetinib is a prescription medicine: every cobimetinib product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was cobimetinib first available?

The earliest FDA record we hold for cobimetinib is from 2015: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when cobimetinib was first used.

What is the brand name of cobimetinib?

Cobimetinib is the generic name. Its brand name is Cotellic.

What is the generic name of Cotellic?

The generic name of Cotellic is cobimetinib. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is cobimetinib?

Cobimetinib belongs to the drug class Kinase Inhibitor, its established pharmacologic class on the FDA label.

What strengths does cobimetinib come in?

Cobimetinib is listed in the FDA's National Drug Code Directory in these forms and strengths. Tablet (by mouth): 20 mg. A listing does not mean every pharmacy stocks every strength.

How much does cobimetinib cost?

What you pay depends on your insurance, your pharmacy and the strength you take. As a benchmark, state Medicaid programs paid an average of $128.81 per 20 mg tablet of brand-name Cotellic over the four quarters through Q1 2026 (CMS's State Drug Utilization Data), before the rebates drug makers pay Medicaid. CMS's weekly pharmacy survey (NADAC) has no price for it, and Medicaid's figure is what a program paid, not the price at the counter. The pharmacy prices section of this page lists every strength priced.

Is there a cobimetinib shortage?

No. Cobimetinib is not on the FDA's drug shortage list as of Nov 21, 2026. A single pharmacy can still run short for a while without a national shortage, and your pharmacist can tell you what they are seeing.

Where can I read the cobimetinib prescribing information (package insert)?

The full FDA-approved prescribing information for cobimetinib, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Genentech, Inc.'s, revised Jul 29, 2026, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Cobimetinib

Skip the scrolling. Ask in your own words and get an answer from Cobimetinib’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Cobimetinib’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Cobimetinib on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, as soon as they can.
Detailed Data & References for Cobimetinib Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Cobimetinib Forms and Strengths (How It Comes)

Cobimetinib comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Cobimetinib inactive ingredients by manufacturer.

Tablet

By mouth
Brands Cotellic (the first brand, 2015)
How this form is used
What it may be used for
  • Cotellic is used with vemurafenib for unresectable or metastatic melanoma with a BRAF V600E or V600K mutation.
  • Cotellic is used as a single agent for adults with histiocytic neoplasms.
Important instructions
  • Cotellic is taken by mouth once daily for the first 21 days of each 28-day cycle.
  • Cotellic can be taken with or without food.
  • If a Cotellic dose is missed or you vomit after taking it, resume with the next scheduled dose.
Available strengths 1 strength
1 FDA-listed product record ⓘ

Cobimetinib on the U.S. Market: Products, Makers and Brands

How Cobimetinib appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 1 Cobimetinib product record with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2015. The one brand name in the directory today is Cotellic; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
1
Brand names ⓘ
1
FDA-listed product records ⓘ
2015
Earliest FDA record ⓘ

How Widely Cobimetinib Is Used (Medicaid Data)

How many Cobimetinib prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

168
Medicaid prescriptions filled (Q1–Q4 2025)
$988,902 paid by Medicaid, before rebates

How commonly is Cobimetinib prescribed? Of the 1,682 medications we measure, Cobimetinib ranks #1,538 by Medicaid prescriptions — more than 9% of them.

Where Cobimetinib ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Cobimetinib product

Pick a strength and form to see its own numbers. Brand and generic versions are counted together.

cobimetinib 20 MG Oral Tablet

168 Medicaid prescriptions (Q1–Q4 2025) 100% of Cobimetinib prescriptions shown $988,902 paid by Medicaid, before rebates ≈ $5,886 per prescription, before rebates

1 of 2 listed NDCs had Medicaid claims. RxNorm 1722370

Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.

Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 2 listed Cobimetinib NDCs had Medicaid claims.

Compare Cobimetinib Products

A representative set of FDA-listed product records for Cobimetinib — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Tablet
20 mg Oral Genentech, Inc. NDA View NDC →

Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Cobimetinib NDCs →

Cobimetinib Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Cobimetinib recalls since July 2021.

✅No Cobimetinib recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Cobimetinib in RxNorm: From Ingredient to Every Form and Strength

RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.

Dose forms
1
Strengths
1
Forms in current FDA listings
1 of 1
In current FDA listings No current FDA listing
Ingredient (IN) Cobimetinib RxCUI 1722365
  1. Dose form (SCDF) Oral Tablet RxCUI 1722369
    In current FDA listings
    Its strength (SCD)

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

What Medicaid Pays for Cobimetinib

CMS’s weekly pharmacy survey (NADAC) has no price for Cobimetinib, so here is what state Medicaid programs paid for it over the four quarters through Q1 2026, before rebates. It is not your price at the counter.

FormStrengthVersion What Medicaid paid
Tablet · Oral 20 mg Cotellic (brand) $128.81 per tablet NDC details & Medicaid use
Why it helps: it shows whether the drug itself is cheap or costly, and whether a cash price you are quoted is in a reasonable range. What you pay also depends on your insurance and pharmacy.

Source: CMS State Drug Utilization Data, total paid divided by units paid for across every state, for each strength’s packages.

Cobimetinib Brand Names

Cobimetinib has one brand name on record: Cotellic. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Cotellic the first brand, 2015

Who Makes Cobimetinib: Manufacturers and Labelers

One company lists Cobimetinib products with the FDA. By number of product records, the largest are Genentech, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Genentech, Inc. 1

Sources for This Cobimetinib Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jul 29, 2026, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Cobimetinib.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
1
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Genentech, Inc.
Linked label effective
Jul 29, 2026
Composite sections available
22
Linked SPL Set ID
c387579e-cee0-4334-bd1e-73f93ac1bde6
Linked SPL Document ID
59075332-49ef-4998-98c4-81e61f57d424
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Genentech, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →